MMSL 2012, 81(1):40-44 | DOI: 10.31482/mmsl.2012.005

NATURAL CHOLINESTERASE INHIBITORS FROM MUSHROOMSReview article

Jiří Patočka ORCID...*
Department of Radiology and Toxicology, Faculty of Health and Social Studies, University of South Bohemia České Budějovice, České Budějovice, Czech Republic

Natural cholinesterase inhibitors were found in many biological sources: bacteria, blue-greens, plants, marine sponges, microscopic fungus, and in a smaller scale also in mushrooms, fruiting body of macroscopis fungus. Only cholinesterase inhibitors isolated from mushrooms are subjects of this minireview. These natural compounds with anticholinergic activity may be considered as prospective drugs against Alzheimer's disease.

Keywords: natural cholinesterase inhibitor; mushroom; alkaloid; Alzheimer's disease

Received: December 11, 2011; Revised: February 12, 2012; Published: March 9, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Patočka, J. (2012). NATURAL CHOLINESTERASE INHIBITORS FROM MUSHROOMS. MMSL, 81(1), 40-44. doi: 10.31482/mmsl.2012.005
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD005593 Go to original source...
    2. Birks, J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2009; (2): CD001191. Go to original source...
    3. Desilets AR, Gickas JJ, Dunican KC. Role of huperzine a in the treatment of Alzheimer's disease. Ann Pharmacother. 2009; 43(3): 514-518. Go to original source... Go to PubMed...
    4. Furukawa-Hibi Y, Alkam T, Nitta A, Matsuyama A, Mizoguchi H, Suzuki K, Moussaoui S, Yu QS, Greig NH, Nagai T, Yamada K. Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice. Behav Brain Res. 2011; 225(1): 222-229. Go to original source... Go to PubMed...
    5. Geissler T, Brandt W, Porzel A, Schlenzig D, Kehlen A, Wessjohann L, Arnold N. Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorg Med Chem. 2010; 18(6): 2173-2177. Go to original source... Go to PubMed...
    6. Giacobini E. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease? Drugs Aging. 2001; 18(12): 891-898. Go to original source... Go to PubMed...
    7. Houghton PJ, Ren Y, Howes MJ. Acetylcholinesterase inhibitors from plants and fungi. Nat Prod Rep 2006; 23: 181-199. Go to original source... Go to PubMed...
    8. Larner AJ. Cholinesterase inhibitors: beyond Alzheimer's disease. Expert Rev Neurother. 2010; 10(11): 1699-1705. Go to original source... Go to PubMed...
    9. Liu J, Zhang HY, Tang XC, Wang B, He XC, Bai DL. Effects of synthetic (-)-huperzine A on cholinesterase activities and mouse water maze performance. Zhongguo Yao Li Xue Bao. 1998; 19(5): 413-416.
    10. Marco L, Carmo Carreiras M. Galanthamine, a natural product for the treatment of Alzheimer's disease. Recent Patents CNS Drug Disc. 2006; 1: 105-111. Go to original source... Go to PubMed...
    11. Orhan I, Sener B. Acetylcholinesterase inhibitors from natural resources. FABAD J Pharm Sci. 2003; 28: 51-58.
    12. Öztürk M, Duru ME, Kivrak S, Mercan-Doğan N, Türkoglu A, Özler MA. In vitro antioxidant, anticholinesterase and antimicrobial activity studies on three Agaricus species with fatty acid compositions and iron contents: a comparative study on the three most edible mushrooms. Food Chem Toxicol. 2011; 49(6): 1353-1360 Go to original source... Go to PubMed...
    13. Patočka J., Kuča K., Jun D. Acetylcholinesterase and butyrylcholinesterase - important enzymes of human body. Acta Medica (Hradec Kralove). 2004; 47(4): 215-228. Go to original source... Go to PubMed...
    14. Prvulovic D, Hampel H, Pantel J. Galantamine for Alzheimer's disease. Expert Opin Drug Metab Toxicol. 2010; 6(3): 345-354. Go to original source... Go to PubMed...
    15. Rakonczay Z. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Acta Biol Hung. 2003; 54(2): 183-189. Go to original source... Go to PubMed...
    16. Rodrigues KF, Costa GL, Carvalho MP, Epifanio RA. Evaluation of extracts produced by some tropical fungi as potential cholinesterase inhibitors. World J Microbiol Biotechnol. 2005; 21: 1617-1621. Go to original source...
    17. Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR. A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology 1999; 38: 181-193. Go to original source... Go to PubMed...
    18. Teichert A, Schmidt J, Porzel A, Arnold N, Wessjohann L. Brunneins A-C, beta-carboline alkaloids from Cortinarius brunneus. J Nat Prod. 2007; 70(9): 1529-1531. Go to original source... Go to PubMed...
    19. Thomsen T, Kewitz H. Selective inhibition of human acetylcholinesterase by galantamine in vitro and in vivo. Life Sci 1990;46:1553-1558. Go to original source... Go to PubMed...
    20. Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. Int J Geriat Psych 2011; 26(2): 150-157. Go to original source... Go to PubMed...
    21. Weinstock M. Selectivity of cholinesterase inhibition: Clinical impplications for the treatment of Alzheimer's disease. CNS Drugs. 1999; 12(4): 307-323. Go to original source...
    22. Yu QS, Atack JR, Rapoport SI, Brossi A. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase. FEBS Lett. 1988; 243(1): 127-130.
    23. Zhao B, Moochhala SM, Tham SY. Biologically active components of Physostigma venenosum. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 812(1-2): 183-192. Go to original source...

    Return to the content